HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
V Tolmachev Selected Research
V Tolmachev Research Topics
Disease
8
Neoplasms (Cancer)
01/2010 - 02/2000
2
Neoplasm Metastasis (Metastasis)
01/2010 - 01/2008
2
Carcinoma (Carcinomatosis)
04/2008 - 01/2008
2
Breast Neoplasms (Breast Cancer)
01/2008 - 03/2006
1
Glioma (Gliomas)
03/2006
1
Glioblastoma (Glioblastoma Multiforme)
03/2006
1
Squamous Cell Carcinoma of Head and Neck
11/2005
1
Ovarian Neoplasms (Ovarian Cancer)
05/2004
1
Adenocarcinoma
05/2004
1
Melanoma (Melanoma, Malignant)
11/2000
Drug/Important Bio-Agent (IBA)
6
Radioisotopes (Radionuclides)
IBA
01/2008 - 02/2000
3
ErbB Receptors (EGF Receptor)
IBA
04/2008 - 03/2006
2
Monoclonal Antibodies
IBA
01/2008 - 11/2005
2
Trastuzumab (Herceptin)
FDA Link
01/2008 - 03/2006
2
Ligands
IBA
12/2007 - 05/2004
1
Peptides (Polypeptides)
IBA
01/2010
1
Membrane Proteins (Integral Membrane Proteins)
IBA
01/2010
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2008
1
N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acid
IBA
12/2007
1
Cys-ZHER2-342 affibody
IBA
12/2007
1
Tenascin
IBA
03/2006
1
(124)I-cMAb U36
IBA
11/2005
1
Melanins (Melanin)
IBA
11/2000
1
Methimazole (Thiamazole)
FDA Link
Generic
11/2000
1
Epidermal Growth Factor (EGF)
IBA
11/2000
1
Thiouracil
IBA
11/2000
1
Octreotide (Sandostatin)
FDA Link
Generic
02/2000
1
Pentetic Acid (DTPA)
FDA Link
Generic
02/2000
Therapy/Procedure
6
Therapeutics
01/2008 - 02/2000